TSLP and atopic eczema: Besides, promoter demethylation is found to contribute to the TSLP overexpression in skin lesion of patients with atopic dermatitis (AD), and treating keratinocytes with demethylating agent AZA reduces the methylation of TSLP promoter and increases TSLP transcription [44].